Navigation Links
Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus
Date:7/1/2009

ROCKVILLE, Maryland, July 1 /PRNewswire-USNewswire/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it expects to have top-line results available on Monday, July 20, from BLISS-52, the first of two pivotal Phase 3 clinical trials of BENLYSTA(TM) (belimumab, formerly LymphoStat-B(R)) in systemic lupus erythematosus (SLE).

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

Senior management will host a conference call to discuss the results on Monday, July 20, 2009 at 8:15 AM Eastern. The BLISS-52 data will be submitted for full presentation at an appropriate scientific meeting.

Investors may listen to the call by dialing 888-632-5010 or 913-312-0402, passcode 8364417, five to 10 minutes before the start of the call. A replay of the conference call will be available within a few hours after the call ends. Investors may listen to the replay by dialing 888-203-1112 or 719-457-0820, confirmation code 8364417.

This conference call also will be webcast and may be accessed at www.hgsi.com. Investors interested in listening to the live webcast should log on before the conference call begins in order to download any software required. The archive of the conference call will remain available for several days.

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

HGS, Human Genome Sciences, BENLYSTA and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

Safe Harbor Statement

This announcement contain
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin
2. Fruit fly steps in to fight human disease
3. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Piper Jaffray Conference
4. Human Genome Sciences Announces Completion of Enrollment in Phase 2b Monthly-Dosing Trial of Albuferon(R)
5. Assessment of safety and efficacy of human embryonic stem cell therapy
6. Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus
7. Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue
8. New MIT radio chip mimics human ear
9. deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease
10. Human Genome Sciences and Novozymes Announce Amendment to Albumin Fusion License Agreement
11. Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...Nov. 5 Cepheid (Nasdaq: ...e speaking at the following investor conferences, ..., , Credit Suisse Healthcare Confe...ovember, 2009 at 10 a.m. Mountain Time, ...ngland, Tuesday, 1 December, 2009 ...
(Date:11/5/2009)...G, Pa., Nov. 5 /PRNewswire-Asia-FirstCall/ -- BMP ...ne" or the "Company") today announced,that the Com... results on,Monday, November 9, 2009, after the ma...nference call at 5:00 pm ET on November 9, 2009,to...y access the call by,dialing 1-888-713-4211 or 1-6...
(Date:11/4/2009)... The Human Anthrax Vaccine Program must be stopped...ure film "A Call to Arms:2009 Edition" a... Immunity: The Human Anthrax Vaccine Story" t...nger of top secret government science turned into ...bility to its victims. It is available for world-...
(Date:11/4/2009)... Nov. 4 Nektar Therapeut...results for the third quarter ended September 30, ...ber 30, 2009 improved to $31.0 million or $0.33 pe...n or $0.40 per share in the third quarter of 2008.... its operating efficiencies as compared to a year ...
Breaking Biology Technology:Cepheid to Webcast Upcoming Financial Presentations 2BMP Sunstone to Report Third Quarter 2009 Financial Results 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10
...uly 10 , - 1st Half-Year Sales Up 16%, - Revisi... than or equal,to)12%, EUR millions ... EURM %Sales EURM %Sales ... change change Sou... 26.8 71 15 Other EU countries (2) 6.9 ...
...ly 10 Quest Diagnostics,Incorporated (NYSE: DGX ...ing, information and services, announced today tha...lic on Tuesday, July 22, before the market,opens, ...l with investors,to discuss the results beginning ...ss the conference call through a live audio webcas...
...0 /PRNewswire-FirstCall/ - Angiotech Pharmaceutica...alty pharmaceutical and,medical device company, an...nited Kingdom, the House of Lords, confirmed in a ...Angiotech,s patents related to its,paclitaxel sten...mented,"The decision represents a significant deve...
Other Biology Technology:Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth 2Quest Diagnostics to Release Second Quarter 2008 Financial Results 2Angiotech wins before the UK House of Lords 2Angiotech wins before the UK House of Lords 3Angiotech wins before the UK House of Lords 4
(Date:11/4/2009)...that deciphered the DNA codes, or genomes, of the ... joined The Genome 10K Project, an international e...uences on 10,000 species of animals for conducting... not be achieved. , Participating in The Genome ... Nov. 5, 2009 issue of the Journal of Heredity , ...
(Date:11/4/2009)...20 Aware, Inc. (Nasdaq: ...y and biometrics software, today reported financia...0, 2009. ,, Michael Tzannes, Aware,s Chairman..., we announced an agreement to sell our DSL and ho...ss semiconductor company being spun out of Infineo...
(Date:11/4/2009)...tists at the University of North Carolina at Chape...lifornia, San Francisco have developed and experim...iseases for existing drugs. , The researchers de...imilar the structures of all known drugs are to th... ligands -- of disease targets within the cell. In...
Breaking Biology News(10 mins):Singapore scientists join international study of 10,000 vertebrates' genomes 2Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Study points to new uses, unexpected side effects of already existing drugs 2US Farms Inc Announces Distribution Partnership With Natures Best 58507 1US Farms Inc Announces Distribution Partnership With Natures Best 58507 2US Farms Inc Announces Distribution Partnership With Natures Best 58507 3Penn Study Asks Protection or Peril 3F Gun Possession of Questionable Value in an Assault 58505 1Penn Study Asks Protection or Peril 3F Gun Possession of Questionable Value in an Assault 58505 2Penn Study Asks Protection or Peril 3F Gun Possession of Questionable Value in an Assault 58505 3Global Biofuels Growth to Double by 2015 14289 1Global Biofuels Growth to Double by 2015 14289 2Global Biofuels Growth to Double by 2015 14289 3Global Biofuels Growth to Double by 2015 14289 4
...Leicester has proposed an immense (1.5km) exhibiti...nd to give a vivid perspective of how quickly huma...accumulate on deep ocean floors at a rate of a few...is called stratigraphy involves drilling vertica... which gives a picture of continually changing lif...
...iversity and the University of California have bee...derwater noise on an unusual whale species and hav...head and ears. , Advances in Finite Element Model...computer processing have made it possible to simul...d whale when a sonar signal is sent out or receive...
...our geometry homework, and for scientists seeking ...zheimers, this advice turns out to be right on the...s, shape determines the all-important function of ...in molecule responsible for Parkinsons binds with ...rupt this interaction -- preventing disease progre...
Other Biology News:How is that whale listening? 2It's all about geometry: Protein contact surfaces hold key to cures 2It's all about geometry: Protein contact surfaces hold key to cures 3
...Microdissection , CapSure HS and CapSure Macro LC...populations of pure cells from tissue sections and...on., Ensure the Integrity of Microdissected Cell... LCM Caps have a patented transfer film bonded to ...
...Microdissection , CapSure HS and CapSure Macro LC...populations of pure cells from tissue sections and...on., Ensure the Integrity of Microdissected Cell... LCM Caps have a patented transfer film bonded to ...
...CM) is the method of choice for thousands of resea...nly instrument to offer both LCM and Laser Cutting...r Cutting provides unprecedented speed and precis...arge numbers of cells. , LCM is a gentle techn...
Hybridizer (220 V) from Dako
Biology Products: